Optiscan Imaging (AU:OIL) — Company Overview, News & Financial Data
Optiscan Imaging develops high-resolution optical imaging systems, focusing on eye diseases and point-of-care solutions.
About Optiscan Imaging
Optiscan Imaging (ASX:OIL) is an Australian medical technology company that develops and commercialises high-resolution optical imaging systems. The company's flagship product is the Optiscan OCT 2000, a non-invasive optical imaging device that is used to diagnose and monitor a range of eye diseases, including glaucoma, diabetic retinopathy, and age-related macular degeneration. Optiscan Imaging is also developing a range of other OCT imaging systems, including a handheld OCT device that is designed for use in point-of-care settings. The company is also developing OCT systems for use in other medical applications, such as cardiology and oncology.
Snapshot
Operations
Products and/or services of Optiscan Imaging
- Optiscan 3D and 2D scanners: High-accuracy scanners for industrial, professional, and high-end applications.
- Optiscan 3D and 2D Pro scanners: Portable and easy-to-use scanners for professional and industrial applications.
- Optiscan 3D and 2D Elite scanners: High-end scanners with advanced features for demanding applications.
- Optiscan software: Software for scanner control, data processing, and analysis.
- Optiscan services: Training, consulting, and support services to help customers get the most out of their Optiscan scanners.
Optiscan Imaging executive team
- Dr. Camile Farah M.A.I.C.D., M.B.A., Ph.D.CEO, MD & Executive Director
- Mr. Darius OoiChief Financial Officer
- Dr. Sanchitha FernandoChief Technology Officer
- Kaylene DawsonGeneral Counsel
- Ms. Belinda WilliamsonChief Commercial Officer
- Ms. Elissa C. Hansen ACSA, B.Com., B.Comm, FCIS, Gad Dip ACG, GAI, GAICCompany Secretary